METFORMIN THERAPY FOR ACNE VULGARIS AMONG MALES AND FEMALES WITHOUT POLYCYSTIC OVARY SYNDROME: A SYSTEMATIC REVIEW AND META-ANALYSIS

Authors

  • AHMED H SULAIMAN Department of Medicine, Faculty of Medicine, Northern Border University, Arar, Kingdom of Saudi Arabia
  • HYDER MIRGHANI Department of Internal Medicine, Faculty of Medicine, University of Tabuk, Tabuk, Kingdom of Saudi Arabia. https://orcid.org/0000-0002-5817-6194
  • OMAIMA A HAMID Department of Obstetrics and Gynecology, Faculty of Medicine, Northern Border University, Arar, Kingdom of Saudi Arabia. https://orcid.org/0009-0009-9120-3236
  • ABDELRAHMAN MOHAMED AHMED ABUKANNA Department of Medicine, Faculty of Medicine, Northern Border University, Arar, Kingdom of Saudi Arabia https://orcid.org/0000-0002-7877-8299
  • HAFIZ OSMAN IBNIDRIS ALMISBAH Department of Medicine, Faculty of Medicine, Northern Border University, Arar, Kingdom of Saudi Arabia https://orcid.org/0000-0002-3507-4646
  • HAIDER OSMAN IBN IDRIS ELMISBAH Department of Surgery, Faculty of Medicine, Northern Border University, Arar, Kingdom of Saudi Arabia https://orcid.org/0000-0002-2232-2540

DOI:

https://doi.org/10.22159/ajpcr.2025v18i3.53774

Keywords:

Acne vulgaris, Metformin,, Doxycycline, Tetracycline, Isotretinoin.

Abstract

Objectives: There is an association between Acne vulgaris and insulin resistance and metabolic syndrome. Although metformin was effective in polycystic ovary syndrome (PCOS) patients, its effects on acne vulgaris among males and females without PCOS are scarce. The study aimed to assess the impact of metformin on acne vulgaris among males and females without PCOS.

Methods: We searched seven databases including Scopus, Web of Science, PubMed, Google Scholar, MEDLINE, EBSCO, and Cochrane Library. We conducted the literature search during October and November of 2024 and the articles were included from inception up to the most recently published research. We used the keywords metformin, doxycycline, tetracycline, isotretinoin, acne vulgaris, acne severity, inflammatory lesions, non-inflammatory lesions, and Global Acne Grading System. A checklist was used to collect the information analyzed by the RevMan System 5.4 (United Kingdom).

Results: Out of a hundred and forty-eight studies identified, we screened 27 full texts, and only five studies were found eligible to be included in the meta-analysis. The studies included 214 patients with study duration of 2–6 months. Metformin was effective in reducing global acne severity scores. However, it was inferior to doxycycline, tetracycline, and isotretinoin, odd ratio, 1.16, 95% CI, 0.37–1.94, Chi-square, 3.95, and p=0.004, and odd ratio, 3.75, 95% CI, 1.85–5.65, Chi-square, 98.32, and p<0.001, respectively.

Conclusion: Metformin was effective in acne vulgaris treatment among males and females without PCOS, p<0.05, but not superior to other systemic therapies. p>0.05. Furthermore, extensive controlled trials are recommended.

Downloads

Download data is not yet available.

Author Biography

OMAIMA A HAMID, Department of Obstetrics and Gynecology, Faculty of Medicine, Northern Border University, Arar, Kingdom of Saudi Arabia.

assistant professor of Obstetrics and Gynecology  

References

Triggle CR, Mohammed I, Bshesh K, Marei I, Ye K, Ding H, et al. Metformin: Is it a drug for all reasons and diseases? Metabolism. 2022;133:155223. doi: 10.1016/j.metabol.2022.155223, PMID: 35640743

American Diabetes Association Professional Practice Committee. 6. Glycemic goals and hypoglycemia: Standards of care in diabetes-2024. Diabetes Care. 2024;47(Suppl 1):S111-25. doi: 10.2337/dc24-S006, PMID: 38078586

Dong Y, Qi Y, Jiang H, Mi T, Zhang Y, Peng C, et al. The development and benefits of metformin in various diseases. Front Med. 2023;17(3):388- 431. doi: 10.1007/s11684-023-0998-6, PMID: 37402952

Dutta S, Shah RB, Singhal S, Dutta SB, Bansal S, Sinha S, et al. Metformin: A review of potential mechanism and therapeutic utility beyond diabetes. Drug Des Dev Ther. 2023;17:1907-32. doi: 10.2147/ DDDT.S409373, PMID: 37397787

Li X, He C, Chen Z, Zhou C, Gan Y, Jia Y. A review of the role of sebum in the mechanism of acne pathogenesis. J Cosmet Dermatol. 2017;16(2):168-73. doi: 10.1111/jocd.12345, PMID: 28556292

Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2163-96. doi: 10.1016/S0140-6736(12)61729-2, PMID: 23245607

Heng AH, Chew FT. Systematic review of the epidemiology of acne vulgaris. Sci Rep. 2020;10(1):5754. doi: 10.1038/s41598-020-62715-3, PMID: 32238884

Hasrat NH, Al-Yassen AQ. The relationship between acne vulgaris and insulin resistance. Cureus. 2023;15(1):e34241. doi: 10.7759/ cureus.34241, PMID: 36852374

Xu S, Zhu Y, Hu H, Liu X, Li L, Yang B, et al. The analysis of acne increasing suicide risk. Medicine (Baltimore). 2021;100(24):e26035. doi: 10.1097/MD.0000000000026035, PMID: 34128844

Andreadi A, Muscoli S, Tajmir R, Meloni M, Minasi A, Muscoli C, et al. Insulin resistance and acne: The role of metformin as alternative therapy in men. Pharmaceuticals (Basel). 2022;16(1):27. doi: 10.3390/ ph16010027, PMID: 36678524

Chandak S, Singh A, Madke B, Jawade S, Khandelwal R. Acne vulgaris and metabolic syndrome: A possible association. Cureus. 2022 May 5;14(5):e24750. doi: 10.7759/cureus.24750, PMID: 35677010

Holzer G, Straßegger B, Volc-Platzer B. Hautmanifestationen beim metabolischen syndrom [Cutaneous manifestations of metabolic syndrome]. Hautarzt. 2016 Dec;67(12):982-8. doi: 10.1007/s00105- 016-3891-2, PMID: 27815622

Prasad SB. Acne vulgaris: A review on pathophysiology and treatment. Asian J Pharm Clin Res. 2016 Jul;9(4):54-9. Melnik BC. Acne vulgaris: The metabolic syndrome of the pilosebaceous follicle. Clin Dermatol. 2018 Jan-Feb;36(1):29-40. doi: 10.1016/j.clindermatol.2017.09.006

Cho M, Woo YR, Cho SH, Lee JD, Kim HS. Metformin: A potential treatment for acne, hidradenitis suppurativa and rosacea. Acta Derm Venereol. 2023 Dec 11;103:adv18392. doi: 10.2340/actadv.v103.18392, PMID: 38078688

Bernardis E, Shou H, Barbieri JS, McMahon PJ, Perman MJ, Rola LA, et al. Development and initial validation of a multidimensional acne global grading system integrating primary lesions and secondary changes. JAMA Dermatol. 2020;156(3):296-302. doi: 10.1001/ jamadermatol.2019.4668, PMID: 31995147

Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. The cochrane collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928. doi: 10.1136/bmj.d5928, PMID: 22008217

Stang A. Critical evaluation of the newcastle-ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603-5. doi: 10.1007/s10654-010-9491-z, PMID: 20652370

Elham B, Somayeh S, Afsaneh SB, Goodarzi A, Ghassemi M, Sepasgozar S, et al. The effect of metformin in the treatment of intractable and late onset acne: A comparison with oral isotretinoin. Iran J Dermatol. 2019;22:47-52.

Fabbrocini G, Izzo R, Faggiano A, Del Prete M, Donnarumma M, Marasca C, et al. Low glycaemic diet and metformin therapy: A new approach in male subjects with acne resistant to common treatments. Clin Exp Dermatol. 2016;41(1):38-42. doi: 10.1111/ced.12673, PMID: 26053680

Robinson S, Kwan Z, Tang MM. Metformin as an adjunct therapy for the treatment of moderate to severe acne vulgaris: A randomized open-labeled study. Dermatol Ther. 2019;32(4):e12953. doi: 10.1111/ dth.12953, PMID: 31044492

Sadati MS, Yazdanpanah N, Shahriarirad R, Javaheri R, Parvizi MM. Efficacy of metformin vs. doxycycline in treating acne vulgaris: An assessor-blinded, add-on, randomized, controlled clinical trial. J Cosmet Dermatol. 2023;22(10):2816-23. doi: 10.1111/jocd.15785, PMID: 37128834

Kamboj P, Kaushik A, Handa S, Dutta P, Saikia UN, Pal A, et al. Effects of metformin on clinical, hormonal and relevant gene expression parameters in patients with acne: An observational study. Clin Exp Dermatol. 2023;48(6):617-22. doi: 10.1093/ced/llad020, PMID: 36656771

Yen H, Chang YT, Yee FJ, Huang YC. Metformin therapy for acne in patients with polycystic ovary syndrome: A systematic review and meta-analysis. Am J Clin Dermatol. 2021;22(1):11-23. doi: 10.1007/s40257-020-00565-5, PMID: 33048332

Lee JK, Smith AD. Metformin as an adjunct therapy for the treatment of moderate to severe acne vulgaris. Dermatol Online J. 2017;23(11): 13030/qt53m2q13s. doi: 10.5070/D32311037242, PMID: 29447630

Gabaton N, Paliza A, Letran E. Double-blind Randomized Controlled Trial On Efficacy and Safety of Metformin As Adjunct to Lymecycline and Topical Adapalene/Benzoyl Peroxide Gel in the Treatment of Moderate-severe Acne [Abstract]. In: 22nd Regional Conference of Dermatology (Asian-Australasian. Singapore: Regional Conference of Dermatology; 2016.

Sung CT, Chao T, Lee A, Foulad DP, Choi F, Juhasz M, et al. Oral metformin for treating dermatological diseases: A systematic review. J Drugs Dermatol. 2020;19(8):713-20. doi: 10.36849/JDD.2020.4874, PMID: 32845585

Monte-Serrano J, Villagrasa-Boli P, Cruañes-Monferrer J, Arbués- Espinosa P, Martínez-Cisneros S, García-Gil MF. Metformina en el tratamiento de enfermedades dermatológicas: Una revisión narrativa [The role of metformin in the treatment of dermatological diseases: A narrative review]. Aten Primaria. 2022;5:102354.

Nguyen S, Nguyen ML, Roberts WS, Wu M, Smith B, Rahaman T, et al. The efficacy of metformin as a therapeutic agent in the treatment of acne vulgaris: A systematic review. Cureus. 2024 Mar 15;16(3):e56246. doi: 10.7759/cureus.56246, PMID: 38623111

Laganà AS, Rossetti P, Buscema M, La Vignera S, Condorelli RA, Gullo G, et al. Metabolism and ovarian function in PCOS women: A therapeutic approach with inositols. Int J Endocrinol. 2016;2016:6306410. doi: 10.1155/2016/6306410, PMID: 27579037

National Institute of Child Health and Human Development. Doxycycline. In: Drugs and Lactation Database (LactMed®). Bethesda: National Institute of Child Health and Human Development; 2006, 2021.

Fallah H, Rademaker M. Isotretinoin in the management of acne vulgaris: Practical prescribing. Int J Dermatol. 2021;60(4):451-60. doi: 10.1111/ijd.15089, PMID: 32860434c

Published

07-03-2025

How to Cite

SULAIMAN, AHMED H, et al. “METFORMIN THERAPY FOR ACNE VULGARIS AMONG MALES AND FEMALES WITHOUT POLYCYSTIC OVARY SYNDROME: A SYSTEMATIC REVIEW AND META-ANALYSIS”. Asian Journal of Pharmaceutical and Clinical Research, vol. 18, no. 3, Mar. 2025, pp. 10-15, doi:10.22159/ajpcr.2025v18i3.53774.

Issue

Section

Original Article(s)

Most read articles by the same author(s)